Cargando…
Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
PURPOSE: To evaluate the changes in visual acuity (VA) and central macular thickness (CMT) after intravitreal dexamethasone (IVD) implantation in intravitreal bevacizumab (IVB) treatment-resistant cases with pseudophakic cystoid macular edema (PCME). METHODS: This study included 10 PCME cases who un...
Autores principales: | Altintas, Ayse Gul Kocak, Ilhan, Cagri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557797/ https://www.ncbi.nlm.nih.gov/pubmed/31179657 http://dx.doi.org/10.3341/kjo.2018.0106 |
Ejemplares similares
-
Intravitreal Bevacizumab for Pseudophakic Cystoid Macular Edema; a Systematic Review
por: Ghasemi Falavarjani, Khalil, et al.
Publicado: (2012) -
Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients
por: Dang, Yalong, et al.
Publicado: (2014) -
Evaluation of Predictive Factors for Successful Intravitreal Dexamethasone in Pseudophakic Cystoid Macular Edema
por: Kakkassery, Vinodh, et al.
Publicado: (2017) -
Longstanding refractory pseudophakic cystoid macular edema resolved using intravitreal 0.7 mg dexamethasone implants
por: Brynskov, Troels, et al.
Publicado: (2013) -
Short-term safety and efficacy of intravitreal 0.7-mg dexamethasone implants for pseudophakic cystoid macular edema
por: Al Zamil, Waseem M.
Publicado: (2015)